
Understanding the pattern and behaviour of vitiligo can help patients receive a more individualised treatment plan
New Delhi [India], October 9: Vitiligo is often described simply as the appearance of white patches on the skin. However, the condition can present in different patterns, and distinguishing between these patterns can help healthcare professionals understand how the disease may behave and what type of management may be appropriate.
Two important clinical patterns are segmental vitiligo and non-segmental vitiligo.
Both involve loss of melanocytes, the pigment-producing cells of the skin, but their distribution and clinical behaviour can differ.
For a condition as individual as vitiligo, Kayakalp Global’s treatment philosophy focuses on assessing the patient rather than applying a uniform protocol. Founded in 1992 by Dr. Shailender Dhawan and Dr. Suman Dhawan, the centre says its treatment approach integrates Ayurveda and modern medicine and is customised according to individual factors.
What is segmental vitiligo?
Segmental vitiligo generally affects one side or a particular region of the body.
It may appear on the face, trunk or a limb and can follow a relatively localised pattern. In many patients, segmental vitiligo progresses relatively quickly during its active phase and subsequently becomes stable.
The clinical behaviour of segmental vitiligo can therefore differ from the more commonly recognised non-segmental form.
Once the disease becomes stable, treatment decisions may also change depending on the patient’s age, location of pigmentation loss, extent of disease and previous treatment response.
What is non-segmental vitiligo?
Non-segmental vitiligo is generally characterised by depigmentation affecting both sides of the body or multiple areas.
Commonly affected locations can include the hands, face, fingers, knees, elbows and areas around body openings.
Unlike segmental vitiligo, non-segmental vitiligo can remain active for longer periods, with new patches appearing or existing patches becoming larger.
This means monitoring disease activity can be an important part of long-term management.
Why does the distinction matter?
The distinction helps healthcare professionals understand the likely behaviour of the condition and formulate a management strategy.
“The type of vitiligo is one of the factors we consider, but it is not the only factor. The same type of vitiligo can behave differently in different patients. Age, disease activity, previous treatment and individual tolerance also need to be considered,” says Dr. Shailender Dhawan, B.A.M.S. (Ayurvedacharya), Founder, Kayakalp Global.
Kayakalp Global’s website describes its treatment philosophy as being based on the individual patient, with factors such as disease severity, previous treatments, drug tolerance, allergies and dietary preferences considered while developing a treatment plan.
Autoimmune associations are more relevant in some patients
Vitiligo is generally understood to involve autoimmune mechanisms. Non-segmental vitiligo, in particular, has recognised associations with other autoimmune conditions.
Thyroid disorders are among the conditions frequently discussed in connection with vitiligo.
This does not mean that every person with vitiligo will develop thyroid disease or another autoimmune disorder.
Instead, a patient’s medical history, symptoms and family history can help determine whether further evaluation is appropriate.
Diagnosis should not be based on appearance alone
A white patch does not automatically mean vitiligo.
Conditions including fungal infections, post-inflammatory hypopigmentation and other pigmentary disorders can sometimes produce similar-looking changes.
A healthcare professional may evaluate the patient’s history and skin pattern and may use tools such as a Wood’s lamp when appropriate.
This is particularly important before beginning long-term treatment.
Treatment depends on the individual
Treatment for vitiligo can include several approaches depending on the patient’s condition.
Modern medical management can include topical treatments and phototherapy, while selected patients may be considered for other interventions depending on disease stability and clinical circumstances.
Kayakalp Global follows an integrated approach that brings Ayurveda and modern medicine together. The organisation describes this as an effort to use the strengths of both systems while focusing on the individual rather than treating every patient through the same protocol.
This does not mean that every patient receives the same combination of treatments. The appropriate plan depends on individual assessment.
Previous treatment matters
Many patients approach specialised vitiligo centres after having already tried one or more treatments.
Previous use of medications, treatment response, allergies and tolerance can influence subsequent treatment decisions.
Kayakalp Global specifically identifies previous treatment history, including previous steroid use, disease severity, drug tolerance and allergy sensitivity among the factors considered while customising treatment.
Stable disease may require a different conversation
One of the important clinical questions in vitiligo is whether the disease is active or stable.
If new patches are appearing or existing patches are expanding, the priority may be controlling disease activity.
When disease has remained stable for an appropriate period, treatment discussions may shift towards repigmentation options, depending on the patient’s circumstances.
This is one reason why patients should not assume that the same treatment will remain appropriate throughout the course of the condition.
Appearance is only one part of the disease
The physical extent of vitiligo does not necessarily correspond to its psychological impact.
A small patch on the face or hands may have a considerable effect on confidence, while another person with more extensive depigmentation may experience relatively little distress.
Patients should therefore be encouraged to communicate how the condition affects their daily life.
Children and adolescents need additional support
When segmental or non-segmental vitiligo appears during childhood or adolescence, parents should consider both medical and emotional needs.
School-related concerns, bullying and questions from peers can influence quality of life.
Helping children understand that vitiligo is not contagious and supporting them in maintaining normal activities can be valuable.
A long-term approach is often necessary
Vitiligo does not necessarily follow a predictable path. Periods of stability may be followed by renewed activity, while treatment responses can vary from one body area to another.
Regular assessment therefore becomes an important component of care.
Kayakalp Global’s current positioning emphasises structured, personalised care rather than quick fixes, with follow-up and monitoring forming part of its treatment philosophy.
The distinction between segmental and non-segmental vitiligo provides useful clinical information, but it is only the beginning of the assessment.
Understanding the type of vitiligo, disease activity, individual medical history and patient’s expectations allows treatment to be approached in a more informed and personalised manner.
Syndicated press content is not written by ED Times. Please verify information.
Read more
How AI Is Helping Indian Railways Keep Elephants Off The Tracks


























